G-BA decision in medical Germany: Evolving Business Models in the Cannabis Industry – Adapting to Regulatory Changes and Market Demands
The recent decision by the German Federal Joint Committee (G-BA) to relax the requirement for prior approval from health insurers for certain medical cannabis prescriptions, expected to take effect in two months, marks a significant shift in the cannabis industry. Should the G-BA’s proposals be approved by the Ministry of Health, an estimated more than […]
